By:
On:
In: Poor company, Stock analysis
Tagged:
With: 0 Comments

Company name Citigroup Inc
Stock ticker C
Live stock price [stckqut]C[/stckqut]
P/E compared to competitors Fair

MANAGEMENT EXECUTION

Employee productivity Poor
Sales growth Poor
EPS growth Poor
P/E growth Good
EBIT growth Poor

ANALYSIS

Confident Investor Rating Poor
Target stock price (TWCA growth scenario) $-0.01
Target stock price (averages with growth) $0.05
Target stock price (averages with no growth) $0.4
Target stock price (manual assumptions) $42.33

The following company description is from Google Finance: http://www.google.com/finance?q=c

Citigroup Inc. is a global diversified financial services holding company whose businesses provide consumers, corporations, governments and institutions with a broad range of financial products and services. It operates in two segments: Citicorp, consisting of Citigroup’s Global Consumer Banking businesses and Institutional Clients Group, and Citi Holdings, consisting of Brokerage and Asset Management, Local Consumer Lending and Special Asset Pool. Global Consumer Banking (which included retail banking and Citi-branded cards in four regions-North America, EMEA, Latin America and Asia) and Institutional Clients Group (which included Securities and Banking and Transaction Services). In February 2012, it sold its 9.85% interest in Housing Development Finance Corporation Ltd. In May 2012, it sold 10.1% interest in Akbank T.A.S. In September 2012, the Company sold EMI Group’s recorded music division, EMI Music, to Vivendi and subsidiary, Universal Music Group.

 

Confident Investor comments: At this price and at this time, I do not think that a Confident Investor can confidently invest in this stock. I realize this is a very popular stock but I do not think that investors are well served by putting their money into this company’s stock.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor.
 

By:
On:
In: Fair company, Stock analysis
Tagged:
With: 0 Comments

Company name Bio-Reference Laboratories Inc
Stock ticker BRLI
Live stock price [stckqut]BRLI[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Poor
Sales growth Good
EPS growth Good
P/E growth Poor
EBIT growth Good

ANALYSIS

Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $27.49
Target stock price (averages with growth) $39.57
Target stock price (averages with no growth) $33.93
Target stock price (manual assumptions) $31.71

The following company description is from Google Finance: http://www.google.com/finance?q=brli

Bio-Reference Laboratories, Inc. (Bio-Reference) is a clinical testing laboratory offering testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. The Company offers a comprehensive list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. It primarily focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health and correctional health care. The Company has a network f approximately 116 patient service centers located in the Northeast (primarily in New York metropolitan super-regional area) for collection of patient specimens. It conducts business in New York State counties, as well as in of New Jersey and Maryland as well as some parts of Pennsylvania, Delaware and Connecticut.

 

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in this stock as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor.

By:
On:
In: Commentary
With: 3 Comments

Occasionally, I will get a Tweet from a follower on Twitter or a communication from my site stating that the market is rigged against individual investors. I couldn’t disagree more. In fact, I think the stock market is probably set up better today for an individual investor than ever before.

I came across an article on Abnormal Returns and the author agrees with my stance. Here are the 5 reasons why he believed it was a great time:

  1. It is easier to be an individual investor than ever before.
  2. It is cheaper to do transactions than ever before.
  3. There is a richer assortment of investment vehicles than ever before.
  4. The social society of blogging and micro-blogging makes it easier to find out relevant information.
  5. It is easier to be smarter than it ever has been. There are so many free portals of investment information that freely offer all of the data that an investor needs.

I was a bit surprised that the author didn’t say that now individual investors have access to my book, The Confident Investor. With my book at your disposal it is now even easier to understand and beat the market. You can purchase my book wherever books are sold such as Amazon, Barnes and Noble, and Books A Million. It is available in ebook formats for Nook, Kindle, and iPad.

By:
On:
In: Good company, Stock analysis
Tagged:
With: 0 Comments

Company name Agilent Technologies Inc.
Stock ticker A
Live stock price [stckqut]A[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Good
Sales growth Poor
EPS growth Good
P/E growth Good
EBIT growth Good

ANALYSIS

Confident Investor Rating Good
Target stock price (TWCA growth scenario) $63.2
Target stock price (averages with growth) $57.79
Target stock price (averages with no growth) $24.09
Target stock price (manual assumptions) $50.66

The following company description is from Google Finance: https://www.google.com/finance?q=NYSE%3AA&sq=a&sp=2&ei=-wZaUcDhHuaG0QH9rQE

Agilent Technologies, Inc. (Agilent) is a measurement company providing bio-analytical and electronic measurement solutions to the communications, electronics, life sciences and chemical analysis industries. During the fiscal year ended October 31, 2011 (fiscal 2011), it had three business segments: electronic measurement business, chemical analysis business and life sciences business. Its electronic measurement business addresses the communications, electronics and other industries. Agilent’s chemical analysis business focuses on the petrochemical, environmental, forensics and food safety industries. Its life sciences business focuses on the pharmaceutical, biotechnology, academic and Government, bio-agriculture and food safety industries. In addition to its three businesses, it conducts research through Agilent Technologies Laboratories (Agilent Labs). In June 2012, the Company acquired cancer diagnostics company, Dako. In August 2012, the Company acquired Aurora SFC Systems, Inc.

 

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in this stock.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor.